These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19299512)

  • 1. Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis.
    Irie N; Takada Y; Watanabe Y; Matsuzaki Y; Naruse C; Asano M; Iwakura Y; Suda T; Matsuo K
    J Biol Chem; 2009 May; 284(21):14637-44. PubMed ID: 19299512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of FTY720-P on EphA2-EphrinA2 bidirectional signaling in osteoclasts].
    Zheng L; Huang D
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 May; 32(5):575-580. PubMed ID: 29806345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.
    Zhao C; Irie N; Takada Y; Shimoda K; Miyamoto T; Nishiwaki T; Suda T; Matsuo K
    Cell Metab; 2006 Aug; 4(2):111-21. PubMed ID: 16890539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17β-estradiol attenuates ovariectomy‑induced bone deterioration through the suppression of the ephA2/ephrinA2 signaling pathway.
    Liu L; Zhou L; Yang X; Liu Q; Yang L; Zheng C; Zhao Y; Zhang Z; Luo X
    Mol Med Rep; 2018 Jan; 17(1):1609-1616. PubMed ID: 29138859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
    J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphyromonas gingivalis lipopolysaccharide regulates ephrin/Eph signalling in human periodontal ligament fibroblasts.
    Li M; Zhang C; Jin L; Matsuo K; Yang Y
    J Periodontal Res; 2017 Oct; 52(5):913-921. PubMed ID: 28590061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY; Lee KH; Kim YK
    Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
    Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
    J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shear stress inhibits IL-17A-mediated induction of osteoclastogenesis via osteocyte pathways.
    Liao C; Cheng T; Wang S; Zhang C; Jin L; Yang Y
    Bone; 2017 Aug; 101():10-20. PubMed ID: 28414140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.
    Li L; Sapkota M; Gao M; Choi H; Soh Y
    Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1.
    Yamashita T; Yao Z; Li F; Zhang Q; Badell IR; Schwarz EM; Takeshita S; Wagner EF; Noda M; Matsuo K; Xing L; Boyce BF
    J Biol Chem; 2007 Jun; 282(25):18245-18253. PubMed ID: 17485464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway.
    Liu YQ; Hong ZL; Zhan LB; Chu HY; Zhang XZ; Li GH
    Sci Rep; 2016 Aug; 6():32260. PubMed ID: 27558652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases.
    Matsuo K; Otaki N
    Cell Adh Migr; 2012; 6(2):148-56. PubMed ID: 22660185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.
    Mukherjee A; Rotwein P
    Mol Cell Biol; 2012 Jan; 32(2):490-500. PubMed ID: 22064480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Porphyromonas gingivalis lipopolysaccharide (Pg-LPS) on the expression of EphA2 in osteoblasts and osteoclasts.
    Gao A; Wang X; Yu H; Li N; Hou Y; Yu W
    In Vitro Cell Dev Biol Anim; 2016 Feb; 52(2):228-34. PubMed ID: 26559065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
    Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
    Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esculetin attenuates receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation through c-Fos/nuclear factor of activated T-cells c1 signaling pathway.
    Baek JM; Park SH; Cheon YH; Ahn SJ; Lee MS; Oh J; Kim JY
    Biochem Biophys Res Commun; 2015 May; 461(2):334-41. PubMed ID: 25887803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation.
    Kim T; Kim K; Lee SH; So HS; Lee J; Kim N; Choi Y
    J Biol Chem; 2009 May; 284(22):15308-16. PubMed ID: 19336404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.